Screening inhibitors of anthrax lethal factor
- 1 July 2002
- journal article
- Published by Springer Nature in Nature
- Vol. 418 (6896) , 386
- https://doi.org/10.1038/418386a
Abstract
The disease anthrax is caused by lethal factor, an enzyme component of the toxin produced by the spore-forming bacterium Bacillus anthracis. Here we describe substrate molecules for this factor that offer a means for high-throughput screening of potential inhibitors for use in anthrax treatment. Our assay should help to answer the urgent call for new and specific therapies to combat this pathogen after its recent emergence as a terrorist bioweapon.Keywords
This publication has 10 references indexed in Scilit:
- Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.Published by Elsevier ,2021
- Quickening the pace of anthrax research: three advances point towards possible therapiesTrends in Microbiology, 2002
- Tackling anthraxNature, 2001
- Crystal structure of the anthrax lethal factorNature, 2001
- AnthraxAnnual Review of Microbiology, 2001
- Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factorBiochemical Journal, 2000
- Novel approaches to targeting neuropeptide systemsTrends in Pharmacological Sciences, 2000
- Protein transduction: unrestricted delivery into all cells?Trends in Cell Biology, 2000
- Anthrax Lethal Factor Cleaves the N-Terminus of MAPKKs and Induces Tyrosine/Threonine Phosphorylation of MAPKs in Cultured MacrophagesBiochemical and Biophysical Research Communications, 1998
- Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal FactorScience, 1998